MARSHALL WACE, LLP - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 65 filers reported holding IRADIMED CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IRADIMED CORP
ValueSharesWeighting
Q1 2022$246,000
-84.6%
5,459
-84.2%
0.00%
-100.0%
Q4 2021$1,599,000
+97.7%
34,580
-8.8%
0.00%
-62.5%
Q1 2020$809,000
-47.7%
37,904
-42.8%
0.01%
-27.3%
Q4 2019$1,548,000
-28.2%
66,222
-35.4%
0.01%
-35.3%
Q3 2019$2,156,000
+41.7%
102,558
+37.8%
0.02%
+30.8%
Q2 2019$1,522,000
+215.8%
74,416
+332.8%
0.01%
+550.0%
Q1 2019$482,00017,1940.00%
Other shareholders
IRADIMED CORP shareholders Q1 2019
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders